UBS/CALL/GALENICA/90.002/0.05/20.06.25 Stock

Warrant

HGALEU

CH1312126225

Market Closed - Bid/Ask 11:20:00 2024-04-11 EDT			After market 11:15:01
0.03 ^CHF	-25.00%		0.025	-16.67%

3 months

-62.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart GALENICA AG

Chart UBS/CALL/GALENICA/90.002/0.05/20.06.25

Latest news about GALENICA AG

Switzerland's Galenica Issues CHF100 Million Bond Due 2031	04-17	MT
Galenica successfully places a bond of over CHF 100 million	04-16	EQ
7th Annual General Meeting: Shareholders approve all proposals	04-10	EQ
Galenica : Invitation to the 7th ordinary Annual General Meeting of Galenica Ltd.	03-19	PU

More news

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	GALENICA AG
Issuer	UBS
	HGALEU
ISIN	CH1312126225
Date issued	2023-12-18
Strike	90 CHF
Maturity	2025-06-20 (402 Days)
Parity	20 : 1
Emission price	0.06 CHF
Emission volume	N/A
Settlement	physical
Currency	CHF

Technical Indicators

Highest since issue	0.09 CHF
Lowest since issue	0.03 CHF
Spread	0.01 CHF
Spread %	33.33%

Company Profile

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Sector

More about the company